Skip to content

Medical-device intelligence

Allergan Inc: FDA clearances and recalls

Research Allergan Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

33 clearance records and 3 recall records in the covered releases, across 1 source company names and 13 product codes. Dated history runs from May 10, 1982 to Aug 8, 2019.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

36 matching records
Device / recordCompany in FDA recordSourceSource date
REFRESH RELIEVA For CONTACTSK190674 · LPNAllergan, Inc.510(k)Aug 8, 2019FDA decision date
XEN Glaucoma Treatment SystemK161457 · KYFAllergan, Inc.510(k)Nov 21, 2016FDA decision date
Natrelle 133 Plus Tissue ExpanderK143354 · LCJAllergan, Inc.510(k)Aug 20, 2015FDA decision date
Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is intended for temporary subcutaneous implantation and …Z-2103-2015 · LCJAllergan IncRecallJul 18, 2015FDA classification date
Natrelle CUI Series Tissue Expanders. Product Usage: Natrelle CUI Series Tissue Expander has been designed for temporary implantation to develop…Z-2104-2015 · LCJAllergan IncRecallJul 18, 2015FDA classification date
Natrelle Re-sterilizable Breast Implant Sizer, Size: 410 cc, Style No. MSZFX410. The product is packaged in a thermoformed tray (double sterile …Z-1988-2015 · MRDAllergan IncRecallJul 7, 2015FDA classification date
REFRESH OPTIVE LENS COMFORT REWETTING DROPSK083812 · LPNAllergan, Inc.510(k)Jul 9, 2009FDA decision date
SINGLE AMPLIFIER FOR BOTOXK051852 · GWLAllergan, Inc.510(k)Sep 14, 2005FDA decision date
COMPLETE BRAND MULTI-PURPOSE SOLUTIONK014202 · LPNAllergan, Inc.510(k)Feb 20, 2002FDA decision date
COMPLETE BRAND MULTI-PURPOSE SOLUTIONK013479 · LPNAllergan, Inc.510(k)Feb 11, 2002FDA decision date
COMPLETE BRAND MULTI-PURPOSE SOLUTIONK003252 · LPNAllergan, Inc.510(k)Feb 21, 2001FDA decision date
MOJAVE CATARACT EXTRACTION SYSTEMK003638 · HQCAllergan, Inc.510(k)Feb 13, 2001FDA decision date
COMPLETE BRAND LUBRICATING AND REWETTING DROPSK003109 · LPNAllergan, Inc.510(k)Nov 21, 2000FDA decision date
COMPLETE BRAND COMFORTPLUS MULTI-PURPOSE SOLUTIONK000164 · LPNAllergan, Inc.510(k)Jun 2, 2000FDA decision date
REFRESH CONTACTS LUBRICATING AND REWETTING DROPSK992028 · LPNAllergan, Inc.510(k)Oct 7, 1999FDA decision date
ULTRACARE NEUTRALIZING TABLETSK984383 · LPNAllergan, Inc.510(k)Dec 18, 1998FDA decision date
COMPLETE BRAND LUBRICATING AND REWETTING DROPSK983150 · LPNAllergan, Inc.510(k)Nov 25, 1998FDA decision date
COMPLETE BRAND MULTI-PURPOSE SOLUTION, COMPLETE BRAND LUBRICATING AND REWETTING DROPSK981168 · LPNAllergan, Inc.510(k)Sep 1, 1998FDA decision date
COMPLETE BRAND MULTI-PURPOSE SOLUTIONK980775 · LPNAllergan, Inc.510(k)Jul 6, 1998FDA decision date
SOVEREIGN CATARACT EXTRACTION SYSTEMK981116 · KYGAllergan, Inc.510(k)May 19, 1998FDA decision date
AMO DIPLOMAX/OPSYS CONSOLEK971186 · HQCAllergan, Inc.510(k)Jun 13, 1997FDA decision date
AMO PRESTIGE DAY PACK (ALLERGAN, INC.)K962402 · HQCAllergan, Inc.510(k)Sep 19, 1996FDA decision date
AMO PHACOFLEX II INTERSECTION SYSTEMK961242 · KYBAllergan, Inc.510(k)Jun 17, 1996FDA decision date
MODEL OPO-32 IRRIGATION SLEEVEK874543 · EIBAllergan, Inc.510(k)Jan 14, 1988FDA decision date
BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVEK870807 · HNOAllergan, Inc.510(k)May 29, 1987FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗